Espen Enerly

Since 2010, Espen har worked as a researcher at the Cancer Registry of Norway. He has primarily studied long-term follow up of subjects who received the HPV-vaccine.

Lately, he has also worked on how to better facilitate research collaboration between the Cancer Registry and the pharmaceutical industry as well as projects within pharmacoepidemiology.

Background

Espen Enerly genetically modified plants and fruit flies in the laboratory at the University of Oslo, which resulted in the degrees Cand. Scient, and Dr. Scient.

Here, the fascination for non-protein genes (RNA genes) was sparked, and an interest in its genomics was later developed and studied at the Institute of Bioinformatics (A*STAR, Singapore).

Espen has later studied the RNA genes relation to breast cancer at the Radium Hospital in Norway.

From May 2019 to 2020 he was the acting leader of section for etiology research. He recently joined the section for molecular epidemiology and infections.

Projects

Resource use patterns and healthcare costs in Patients with EGFR Mutation-Positive Locally Advanced or Metastatic NSCLC in a Real World Setting (RECEIPT) (Norwegian only)

INSPIRE (Norwegian only)

Previous projects:

SVEIP - EFFECT OF SCHOOL BASED HPV-VACCINATION IN THE POPULATION

LTFU: LONG-TERM FOLLOW UP OF SUBJECTS PARTICIPATING IN THE CLINICAL TRIALS OF THE HPV-VACCINE

REGISTER BASED DESCRIPTIVE STUDY OF PROGRESSION AND REGRESSION OF WOMEN WITH PRECANCEROUS CERVICAL LESIONS (Norwegian only)